IRD · Categories · Coverage
IRD - Analyst coverage initiated
Opus Genetics Inc. (IRD) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for IRD
- Guggenheim initiated coverage on Opus Genetics with a new price targetGuggenheim initiated coverage of Opus Genetics with a rating of Buy and set a new price target of $16.00
- Leerink Partners initiated coverage on Opus Genetics with a new price targetLeerink Partners initiated coverage of Opus Genetics with a rating of Outperform and set a new price target of $10.00
- Citizens initiated coverage on Opus Genetics with a new price targetCitizens initiated coverage of Opus Genetics with a rating of Mkt Perform and set a new price target of $12.00
- Cantor Fitzgerald initiated coverage on Opus Genetics with a new price targetCantor Fitzgerald initiated coverage of Opus Genetics with a rating of Overweight and set a new price target of $15.00
- Oppenheimer initiated coverage on Opus Genetics with a new price targetOppenheimer initiated coverage of Opus Genetics with a rating of Outperform and set a new price target of $10.00
- BTIG Research initiated coverage on Opus Genetics with a new price targetBTIG Research initiated coverage of Opus Genetics with a rating of Buy and set a new price target of $7.00
- B. Riley Securities initiated coverage on Opus Genetics with a new price targetB. Riley Securities initiated coverage of Opus Genetics with a rating of Buy and set a new price target of $9.00
- Piper Sandler initiated coverage on Opus Genetics with a new price targetPiper Sandler initiated coverage of Opus Genetics with a rating of Overweight and set a new price target of $7.00
- Wedbush initiated coverage on Opus Genetics with a new price targetWedbush initiated coverage of Opus Genetics with a rating of Outperform and set a new price target of $8.00
- Chardan Capital Markets initiated coverage on Opus Genetics with a new price targetChardan Capital Markets initiated coverage of Opus Genetics with a rating of Buy and set a new price target of $9.00
- Craig Hallum initiated coverage on Opus Genetics with a new price targetCraig Hallum initiated coverage of Opus Genetics with a rating of Buy and set a new price target of $6.00